期刊文献+

我国2015年新生儿遗传代谢病筛查指标切值的调查 被引量:22

Investigation on the cut-off values of screening markers for neonatal inherited metabolic diseases in China,2015
下载PDF
导出
摘要 目的调查我国新生儿遗传代谢病筛查检验指标的切值情况,为新生儿遗传代谢病筛查工作提供建议。方法调取国家卫生计生委临床检验中心2015年全国新生儿遗传代谢病筛查指标苯丙氨酸(Phe)、促甲状腺激素(TSH)、葡萄糖-6-磷酸脱氢酶(G6PD)和17-羟孕酮(17-OHP)室间质量评价回报结果中切值相关信息,包括实验室编码、单位名称、所在地区、指标切值、切值来源、方法学原理、仪器、试剂和校准品。分析不同地区、方法学原理和切值来源对4个指标切值大小的影响。结果220家实验室中,切值来源中所占比例最高的3项依次为:试剂厂家说明书(48.2%-69.8%)、实验室自行确定(27.7%~35.2%)和新生儿疾病筛查技术规范(0.0%-20.0%)。参加研究的机构数量最多的3个省份分别为广东(25家)、山东(17家)和江苏(16家)。对切值情况调查显示:Phe切值分布在1.60~5.00mg/dL;TSH切值分布在4.82-18.00mlU/L;G6PD切值在2.00~10.00U/gHb;17-0HP切值在23.20~60.00nmol/L范围内。对于Phe指标,各来源组和方法组切值差异均有统计学意义(P均〈0.05);对于TSH指标,各来源组间切值差异有统计学意义(P〈0.05),但方法组间差异无统计学意义(P〉0.05);对于G6PD和17-OHP指标,不同来源和方法组的切值差异均无统计学意义(P均〉0.05)。结论各个检验指标切值较为一致,有个别实验室切值差异较大,建议各实验室对现有不同方法的切值进行评审。 Objective To investigate the cut-off values of screening markers for neonatal inherited metabolic diseases (IMD) in Chi- na, and then provide the suggestions for the screening of neonatal IMD. Methods The data related to the cut-off values of phenylala- nine ( Phe ), thyroid stimulating hormone ( TSH ), glucose-6-phosphate dehydrogenase ( G6PD ) and 17-hydroxyprogesterone ( 17- OHP) from the external quality assessment (EQA) program of neonatal IMD performed by National Center for Clinical Laboratories of China in 2015, including lab coding, institution name, location, cut-off value, source of cut-off value, methodological principle, in- strnment, reagent and calibrator, were collected. Then, the effects of different region, methodology and source of cut-off value on the cut-off value were analyzed. Results A total of 220 laboratories submitted their data. The main sources of cut-off values were from re- agent manufacturers' instructions (48.2% - 69.8% ), calculated values by laboratories themselves (27.7% - 35.2% ), and the technical specification for neonatal disease screening (0.0% - 20.0% ). The province with the largest number of institutions attending the program was Guangdong (25), followed by Shandong (17) and Jiangsu (16), respectively. The ranges of the cut-off values were 1.60 - 5.00 mg/dL for Phe, 4.82 - 18.00 mIU/L for TSH, 2.00 - 10.00 U/glib for G6PD, and 23.20 - 60.00 nmol/L for 17- OHP, respectively. For Phe, there were significant differences in the cut-off values between different sources and between different meth- ods (P 〈0.05 ), while for TSH, there was significant difference between different sources ( P 〈0.05 ) but nut between different methods (P 〉0.05). However, for G6PD and 17-OHP, there was no any significant difference in the cut-off values between different sources or between different methods (P 〉 0.05). Conclusion The distribution of the cut-off values for each marker is relatively unified except large variation existed in several laboratories, indicating that the cut-off values should be reviewed by neonatal screening laboratories.
出处 《临床检验杂志》 CAS CSCD 2016年第9期706-709,共4页 Chinese Journal of Clinical Laboratory Science
基金 北京市自然科学基金(7143182) 北京医院课题(BJ-2015-025)
关键词 新生儿遗传代谢病筛查 切值 苯丙氨酸 促甲状腺激素 葡萄糖-6-磷酸脱氢酶 17羟孕酮 neonatal inherited metabolic disease, screening cut-off value phenylalanine thyroid stimulating hormone glucose-6-phosphate dehydrogenase 17-hydroxyprogesterone
  • 相关文献

参考文献5

二级参考文献27

  • 1田国力,许洪平,朱伟明,管翌华,王燕敏.新生儿苯丙酮尿症两种实验室筛查方法的质量评价[J].检验医学,2007,22(2):171-173. 被引量:10
  • 2Guthrie R. Screening for "inborn errors of metabolism" in the newborn infant: a multiple test program[J]. Birth Defects Original Article Series IV, 1962 = 92-98.
  • 3Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants[J]. Pediatrics, 1963,32:338-343.
  • 4Guthrie R. The origin of newborn screening[J]. Screening, 1992,1:5- 15.
  • 5Bradford LT, Alissa J, Donna W. Status of Newborn Screening Programs in the United States[J]. Diatrics,2006, 117(5 ):212 -252.
  • 6国家质量技术监督局.GB/T 15483.1-1999,利用实验室间比对的能力验证.第1部分:能力验证计划的建立和运作[M].北京:中国标准出版社,1999.
  • 7国家质量监督局.GB/T 20470-2006,临床实验室室间质量评价要求[M].北京:中国标准出版社,2006.
  • 8ISBN 1-56238-406-6. How to Define and Determine Reference Inter- vals in the Clinical Laboratory; Approved Guideline-Second Edition, C28-A2[S]. Clinical and Laboratory Standards Institute,2000.
  • 9Zytkoviez TI4, Fitzgerald EF, arsden D, et al, Tandem mass spec- trometric analysis for amlno, organic, and fatty acid disorders in new- born dried blood spots: a two-year summary from the New England Ne,~born Screening Program [ J ]. Clio Chem, 2001,47 ( 11 ) : 1945- 1955.
  • 10Wileken B, Wiley V, Hammond J, et al. Screening newborns for in- born errors of metabolism by tandem mass spectrometry[ J]. N Engl J Med ,2003,348 ( 23 ) :2304-2312.

共引文献50

同被引文献176

引证文献22

二级引证文献99

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部